These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 16492484

  • 1. Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
    Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN.
    Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484
    [Abstract] [Full Text] [Related]

  • 2. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA, deSouza IS, Nishijima DK, Senecal EL, Setnik GS, Stair TO, Ruskin JN, Ellinor PT.
    Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
    Tomlinson DR, Cherian P, Betts TR, Bashir Y.
    Emerg Med J; 2008 Jan; 25(1):15-8. PubMed ID: 18156531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R.
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [Abstract] [Full Text] [Related]

  • 7. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS, Pierangeli A.
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [Abstract] [Full Text] [Related]

  • 8. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
    Stiell IG, Clement CM, Symington C, Perry JJ, Vaillancourt C, Wells GA.
    Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
    [Abstract] [Full Text] [Related]

  • 9. The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients: five-year, single-center experience.
    Inamdar V, Mehta S, Juang G, Cohen T.
    J Invasive Cardiol; 2006 Jul; 18(7):313-5. PubMed ID: 16816436
    [Abstract] [Full Text] [Related]

  • 10. [Arrhythmia recurrence in patients with an old myocardial infarct treated by implantable defibrillator: an analysis according to the initial clinical presentation].
    Vacca M, Mont L, Valentino M, Sambola A, Madariaga R, Matas M, Brugada J.
    Rev Esp Cardiol; 1999 Dec; 52(12):1066-74. PubMed ID: 10659653
    [Abstract] [Full Text] [Related]

  • 11. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone.
    Somberg JC, Timar S, Bailin SJ, Lakatos F, Haffajee CI, Tarjan J, Paladino WP, Sarosi I, Kerin NZ, Borbola J, Bridges DE, Molnar J, Amio-Aqueous Investigators.
    Am J Cardiol; 2004 Mar 01; 93(5):576-81. PubMed ID: 14996582
    [Abstract] [Full Text] [Related]

  • 12. Adenosine for wide-complex tachycardia: efficacy and safety.
    Marill KA, Wolfram S, Desouza IS, Nishijima DK, Kay D, Setnik GS, Stair TO, Ellinor PT.
    Crit Care Med; 2009 Sep 01; 37(9):2512-8. PubMed ID: 19623049
    [Abstract] [Full Text] [Related]

  • 13. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest.
    Skrifvars MB, Kuisma M, Boyd J, Määttä T, Repo J, Rosenberg PH, Castren M.
    Acta Anaesthesiol Scand; 2004 May 01; 48(5):582-7. PubMed ID: 15101852
    [Abstract] [Full Text] [Related]

  • 14. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children.
    Laird WP, Snyder CS, Kertesz NJ, Friedman RA, Miller D, Fenrich AL.
    Pediatr Cardiol; 2003 May 01; 24(2):133-7. PubMed ID: 12370794
    [Abstract] [Full Text] [Related]

  • 15. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR.
    Can J Cardiol; 1996 Apr 01; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [Abstract] [Full Text] [Related]

  • 16. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
    Vergara G, Disertori M, Inama G, Guarnerio M, Bettini R, Durante G, Stirpe E, Furlanello F.
    G Ital Cardiol; 1984 Dec 01; 14(12):972-81. PubMed ID: 6532893
    [Abstract] [Full Text] [Related]

  • 17. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T, Groysman R, Meilichov I.
    Pharmacotherapy; 2008 Jan 01; 28(1):14-9. PubMed ID: 18154469
    [Abstract] [Full Text] [Related]

  • 18. [Sustained monomorphic ventricular tachycardia in patients with structural heart disease. Different arrhythmogenic substrates, different options of palliative and curative treatment in the era of three-dimensional mapping].
    Fiala M, Chovanzík J, Neuwirth R, Nykl I, Szymeczek H, Nevralová R, Jiravský O, Branny M.
    Vnitr Lek; 2006 Jun 01; 52(6):577-89. PubMed ID: 16871761
    [Abstract] [Full Text] [Related]

  • 19. Timing of defibrillation shocks for resuscitation of rapid ventricular tachycardia: does it make a difference?
    Turner I, Turner S, Grace AA.
    Resuscitation; 2009 Feb 01; 80(2):183-8. PubMed ID: 19091453
    [Abstract] [Full Text] [Related]

  • 20. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma.
    Putland M, Kerr D, Kelly AM.
    Ann Emerg Med; 2006 Jun 01; 47(6):559-63. PubMed ID: 16713785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.